Persons with HIV are at increased risk for hepatitis B virus
infection and vaccination is recommended. However, liver-related deaths
among HIV patients, in which hepatitis B plays a central role, account
for the largest proportion of deaths not related to AIDS.
‘A multifaceted approach is required to eliminate hepatitis B virus infection by increasing vaccination for HIV patients.’
In 2016, the
World Health Organization (WHO) resolved to eliminate HBV infection as a
public health threat by 2030. The findings are
published in Annals of Internal Medicine.
To estimate the prevalence of hepatitis B vaccination among HIV
patients and establish a benchmark for the WHO initiatve, researchers
from the Centers for Disease Control and Prevention (CDC) surveyed a
nationally representative sample of 18,089 adults receiving HIV medical
care who participated in the Medical Monitoring Project during 2009 to
They found that more than one third of U.S HIV patients had not
been vaccinated for hepatitis B. In addition, only 1 in 10 of these
vaccination candidates was vaccinated in the course of 1 year of ongoing
According to the researchers, meeting goals for hepatitis B
elimination will require a multifaceted approach to increasing
vaccination of HIV patients.
Particular attention should be focused on
increasing vaccination of patients who receive care in private practices
and at facilities not funded by the Ryan White HIV/AIDS Program.